Roche
Search results
The Genentech Foundation supports programs that develop life sciences leaders and diversify healthcare workforce at SF State. Learn more about the $14M grant, the pipeline of medicines, and the patient financial support.
- Advancing Inclusive Research
Advancing Inclusive Research ® (AIR) is an innovative...
- Patient Financial Support
If you need help understanding your health insurance...
- Clinical Trial Information
In rare circumstances, Genentech may provide patients with...
- Our Pipeline
Pipeline. Rigorous and groundbreaking science has always...
- Our Medicines
You may also report side effects to Genentech at (888)...
- Giving
We also support the Genentech Foundation, a U.S.-based,...
- Publications
Genentech scientists are encouraged to be creative and...
- Ophthalmology
Advancing Diversity & Inclusion in Ophthalmology. Serving...
- Advancing Inclusive Research
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Genentech is a biotechnology company that discovers and develops medicines for serious and life-threatening diseases. Learn about its history, mission, values, and podcast series on human biology.
Find prescribing information, medication guides, healthcare provider letters, and safety data sheets for Genentech's biologic products. Browse by product name, indication, or therapeutic area.
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech is a biotechnology company that develops and markets medicines for various diseases. Learn about their medicines, coverage options, clinical trials, and patient support programs.
Genentech | 748,496 followers on LinkedIn. About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions.
